Containing Coronavirus Through Innovation and Investment:

An Xconomy Special Report

Basedon pertinent news and analysis as well as discussion from industry experts during the Combatting Coronavirus live panel at BIO-Europe Spring®, this reportbrings you the latest coronavirus news from the frontlines as top biotech and investment players offer their best plans and current progress in stemming and ultimately defeating the current worldwide pandemic.

JUST RELEASED: SPECIAL REPORT ON COVID-19


Xconomy

2 International Place #2610

Boston, MA 02110-4104

Thespecialreportincludes:

  • Regeneron,Moderna, J&J and the Ongoing Battle Against COVID-19

  • Funding Coronavirus R&D Efforts: Governments and the Private Sector Will Step Up

  • Getting Back to Business: Lessonsfrom China Two Months On

  • Rapid Response Vaccine Capacity Vital for Pandemics, Say Experts

  • Investors Shaken by Coronavirus Sow Seeds ofM&A, Financing Slowdown

  • One Billion Doses: CureVac Gains $88m to Support Capacity for COVID-19 mRNA Vaccine

FREE DOWNLOAD: